Protara Therapeutics Inc

TARA's Fundamental analysis

Protara Therapeutics Inc 's sales fell in II. Quarter 2020 from the same quarter a year ago.

Biotechnology & Drugs industry recorded growth of revenues by 13.14 %

• More on TARA's Growth

TARA's Valuation comparisons

Protara Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 8.61 in trailing twelve-month period.

Company

PE TTM

Industry

PE TTM

Biotechnology & Drugs industry's Price to Sales ratio is at 5.47.

Protara Therapeutics Inc Price to Book Ratio is at 2.36 lower than Indusry Avg. of 729.47. and higher than S&P 500 Avg. of -0.02

• More on TARA's Valuation

Total Debt (Millions $)	1
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	-
Tangible Book Value (Per Share $)	5.15

TARA's Valuation comparisons

Protara Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 8.61 in trailing twelve-month period.

Company

PE TTM

Industry

PE TTM

Market Capitalization (Millions $)	140
Shares Outstanding (Millions)	6
Employees	-
Revenues (TTM) (Millions $)	-
Net Income (TTM) (Millions $)	-20
Cash Flow (TTM) (Millions $)	16
Capital Exp. (TTM) (Millions $)	-0

Total Debt (Millions $)	1
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover Ratio (TTM)	-
Tangible Book Value (Per Share $)	5.15

Market Capitalization (Millions $)	140
Shares Outstanding (Millions)	6
Employees	-
Revenues (TTM) (Millions $)	-
Net Income (TTM) (Millions $)	-20
Cash Flow (TTM) (Millions $)	16
Capital Exp. (TTM) (Millions $)	-0

	*Ratio*
• Capital Ratio (MRQ)	9.61
• Total Debt to Equity (MRQ)	0.02
• Tangible Leverage Ratio (MRQ)	0.13
• Asset Turnover Ratio (TTM)	-
• Inventory Turnover Ratio (TTM)	-

TARA's Profitability Comparisons

• More on TARA's Key Ratios

At a Glance

Growth Rates

Profitability

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

Dividend Comparisons

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar CBT's Profile Stock Price CBT's Financials Business Description Fundamentals Charts & Quotes CBT's News Suppliers CBT's Competitors Customers & Markets Economic Indicators CBT's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Free Stock Market News Feeds

Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071